1. Biopsy-Verified Bronchiolitis Obliterans and Other Noninfectious Lung Pathologies after Allogeneic Hematopoietic Stem Cell Transplantation 
Hilde Hylland Uhlving, Claus B. Andersen, Ib Jarle Christensen, Magdalena Gormsen, Karen Damgaard Pedersen, Frederik Buchvald, Carsten Heilmann, Kim Gjerum Nielsen, Jann Mortensen, Claus Moser, Henrik Sengeløv, Klaus Gottlob Müller 
Biology of Blood and Marrow Transplantation 
Volume 21, Issue 3, Pages (March 2015)
DOI: /j.bbmt
Copyright © 2015 American Society for Blood and Marrow Transplantation Terms and Conditions

2. Figure 1 Study population. TBB indicates transbronchial biopsy.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2015 American Society for Blood and Marrow Transplantation Terms and Conditions

3. Figure 2
Development of lung function in patients with biopsy-verified BO compared with patients with other noninfectious pulmonary pathologies (non-BO). *P value relates to the difference between BO and non-BO patients in PF parameters from time of lung biopsy and throughout follow-up. **P value relates to the difference between BO and non-BO patients in change in PF parameters from time of lung biopsy.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2015 American Society for Blood and Marrow Transplantation Terms and Conditions

4. Figure 3
(A) Overall survival in time from HSCT in patients with biopsy-verified BO compared with patients with other noninfectious pulmonary pathology (non-BO) and HSCT patients without lung biopsy from the same period. 1P value of difference between the 3 groups. (B) Overall survival in time from lung biopsy.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2015 American Society for Blood and Marrow Transplantation Terms and Conditions